Kisqali 200 MG daily dose UU 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FQU2R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,167
Award facts
- Contract value 100% obligated
- $45,167.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,167.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Kisqali 200 mg daily dose in 21-unit packages, with an ultimate completion date of February 3, 2026. The award is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal government healthcare systems. The place of performance is located in Conshohocken, PA 19428.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic drugs, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Kisqali (ribociclib) is an oncology medication, consistent with AmerisourceBergen's portfolio of therapeutic products delivered through the DLA supply chain to military treatment facilities and federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FQU2R?
SPE2DR26FQU2R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FQU2R worth?
The government has obligated $45,167 on SPE2DR26FQU2R.
Is contract SPE2DR26FQU2R an order under another contract?
Yes. SPE2DR26FQU2R is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU2R competed?
The extent of competition for SPE2DR26FQU2R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award